BAJAJHCARE vs WOCKPHARMA: Stock Comparison

Bajaj Healthcare Limited vs Wockhardt Ltd

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Wockhardt Ltd is the larger company by market capitalisation. Bajaj Healthcare Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Wockhardt Ltd shows faster revenue growth, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bajaj Healthcare Limited and Wockhardt Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BAJAJHCARE is more favourable on 5 of 13 scored metrics and WOCKPHARMA on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,362 Cr vs ₹1,087 Cr
P/E Ratio
BAJAJHCARE has a lower P/E
64.24x vs 144.46x
P/B Ratio
BAJAJHCARE has a lower P/B
2.34x vs 6.23x
EPS
WOCKPHARMA has higher earnings per share
₹13.1 vs ₹7
Dividend Yield
BAJAJHCARE has a higher dividend yield
0.26% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs -0.9%
Qtr Sales Growth
WOCKPHARMA has stronger quarterly sales growth
29.9% vs -0.91%
Qtr Profit Growth
WOCKPHARMA has stronger quarterly profit growth
688% vs 19.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBAJAJHCAREWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBAJAJHCAREWOCKPHARMA
Live Price₹322.85₹1,860.7
Day Change-12.59%-1.88%
Volume14.05 L7.29 L
52-Week High₹537.95₹2,422.3
52-Week Low₹272.35₹1,086.7
Distance from 52W High-39.99%-23.18%

Valuation

MetricBAJAJHCAREWOCKPHARMA
Market Cap₹1,087 Cr₹30,362 Cr
P/E Ratio64.24x144.46x
P/B Ratio2.34x6.23x
EPS₹7₹13.1
Book Value₹167.01₹304
Dividend Yield0.26%0%

Growth

MetricBAJAJHCAREWOCKPHARMA
Revenue Growth (TTM YoY)-0.9%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-0.91%29.9%
Qtr Profit Growth19.2%688%

Profitability & Leverage

MetricBAJAJHCAREWOCKPHARMA
ROE9.4%6.11%
ROCE11.5%7.55%
Net Margin2.56%3.3%
Operating Margin17.2%19.3%
Debt to Equity0.47x0.45x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBAJAJHCAREWOCKPHARMA
Promoter Holding58.59% 0.3 pp49.08%
FII Holding2.19% 0.21 pp7.09% 0.1 pp
DII Holding1.92% 0.99 pp10.96% 0.41 pp
Public Holding37.3% 0.48 pp32.83% 0.52 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bajaj Healthcare Limited and Wockhardt Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.